Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Bigkahuna57on Nov 05, 2023 9:34am
204 Views
Post# 35718207

RE:RE:RE:RE:RE:RE:RE:Of interest

RE:RE:RE:RE:RE:RE:RE:Of interestRe Dumb,
The only points one may conclude about your posts are you don't understand how a drug is brought to market, or the clinical trial process, and you don't understand the data that's been presented and peer reviewed?  For the past year the data has continued to show better results for the tested groups.  Clearly you don't know how to run a company and control it if it's publicly traded.  Try making a contribution that we can understand that's worthy of an email besides displaying your stupidity and willful ignorance. 

Good luck to all.
Regards, BK.
<< Previous
Bullboard Posts
Next >>